Ford Master Tech Bright Kim reveals the 40-minute secret to dropping an F-150 5.0L engine. As oil consumption issues trigger ...

Ford is recalling 254,000 SUVs in the United States after discovering a software problem that can disable rearview cameras ...

Gastric cancer (GC) remains a leading cause of cancer mortality, largely owing to metastasis driven by a highly dynamic tumor microenvironment (TME). Immunosuppressive regulatory T cells (Tregs) and ...

Is 1,863 miles and a quart of oil the start of another engine failure for this Ford F-150 owner, or is this "acceptable" consumption for the notorious 5.0L? Jack Stack on the Ford F-150 Owners ...

Aaron, a 27-year automotive technician and lifelong car enthusiast, attended Specs Howard School of Media Arts and learned the fundamentals of digital video and editing, shot composition and writing.

The version history of the Ford Power-Up updates for the Ford SYNC Version 4 and 4a hardware developed by Ford Motor Company began with the release of the 2021 Mustang Mach-E in December 2020. This ...

From the moment the first 2024 Mustang rolled off a dealer lot, enthusiasts have clamored for the ability to tune the factory engine control unit. Alas, Ford decided to encrypt its modern software to ...

ABSTRACT: Epigenetics can be defined as a heritable or reversible change in gene expression that is not accompanied by changes in DNA sequences. Epigenetics provides an additional layer of ...

Background: As vascular sentries, platelets, and their ability to release a host of bioactive molecules, are critical for vascular homeostasis and hemostasis. Despite data linking platelet activation ...

Ford is recalling more than 556,000 vehicles, according to the National Highway Traffic Safety Administration. For a full list of recalls or to see if your car needs repairs, visit the NHTSA website.

SEOUL, South Korea, May 13, 2025 /PRNewswire/ -- Hyundai ADM Bio (KOSDAQ symbol 187660) today announced the voluntary withdrawal of its Investigational New Drug (IND) application for Phase 1 clinical ...